Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer

Open access
Yu, Jun, Wu, William K K, Li, Xiangchun, He, Jun, Li, Xiao-Xing, Ng, Simon S M, Yu, Chang, Gao, Zhibo, Yang, Jie, Li, Miao, Wang, Qiaoxiu, Liang, Qiaoyi, Pan, Yi, Tong, Joanna H, To, Ka F, Wong, Nathalie, Zhang, Ning, Chen, Jie, Lu, Youyong, Lai, Paul B S, Chan, Francis K L, Li, Yingrui, Kung, Hsiang-Fu, Yang, Huanming, Wang, Jun, Sung, Joseph J Y · 2015 · Gut

Abstract

Background: Characterisation of colorectal cancer (CRC) genomes by next-generation sequencing has led to the discovery of novel recurrently mutated genes. Nevertheless, genomic data has not yet been used for CRC prognostication. Objective: To identify recurrent somatic mutations with prognostic significance in patients with CRC. Method: Exome sequencing was performed to identify somatic mutations in tumour tissues of 22 patients with CRC, followed by validation of 187 recurrent and pathway-related genes using targeted capture sequencing in additional 160 cases. Results: Seven significantly mutated genes, including four reported ( APC , TP53 , KRAS and SMAD4 ) and three novel recurrently mutated genes ( CDH10 , FAT4 and DOCK2 ), exhibited high mutation prevalence (6–14% for novel cancer genes) and higher-than-expected number of non-silent mutations in our CRC cohort. For prognostication, a five-gene-signature ( CDH10 , COL6A3 , SMAD4 , TMEM132D , VCAN ) was devised, in which mutation(s) in one or more of these genes was significantly associated with better overall survival independent of tumor-node-metastasis (TNM) staging. The median survival time was 80.4 months in the mutant group versus 42.4 months in the wild type group (p=0.0051). The prognostic significance of this signature was successfully verified using the data set from the Cancer Genome Atlas study. Conclusions: The application of next-generation sequencing has led to the identification of three novel significantly mutated genes in CRC and a mutation signature that predicts survival outcomes for stratifying patients with CRC independent of TNM staging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2013-306620

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 188

Metadata

Authors
Yu, J., Wu, W. K. K., Li, X., He, J., Li, X.-X., Ng, S. S. M., Yu, C., Gao, Z., Yang, J., Li, M., Wang, Q., Liang, Q., Pan, Y., Tong, J. H., To, K. F., Wong, N., Zhang, N., Chen, J., Lu, Y., Lai, P. B. S., Chan, F. K. L., Li, Y., Kung, H.-F., Yang, H., Wang, J., & Sung, J. J. Y.
Venue
Gut
Publisher
BMJ
Published
2014-06-20
Volume
64
Issue
4
Pages
636-645
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2142488410
Cited by
188
References
2
FWCI
12.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. https://app.cochat.ai/papers/10.1136/gutjnl-2013-306620
The paper
Yu, J., Wu, W. K. K., Li, X., He, J., Li, X.-X., Ng, S. S. M., Yu, C., Gao, Z., Yang, J., Li, M., Wang, Q., Liang, Q., Pan, Y., Tong, J. H., To, K. F., Wong, N., Zhang, N., Chen, J., Lu, Y., . . . Sung, J. J. Y. (2015). Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2013-306620

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.